JD Health International, Inc.JD Health International, Inc.JD Health International, Inc.

JD Health International, Inc.

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪184.81 B‬CNY
1.45CNY
‪4.24 B‬CNY
‪59.25 B‬CNY
‪1.03 B‬
Beta (1Y)
1.27
Employees (FY)
‪3.56 K‬
Change (1Y)
+446 +14.30%
Revenue / Employee (1Y)
‪16.62 M‬CNY
Net income / Employee (1Y)
‪1.19 M‬CNY

About JD Health International, Inc.


CEO
En Lin Jin
Headquarters
Beijing
Founded
2018
ISIN
KYG5074A1004
FIGI
BBG01GXJWFF0
JD Health International, Inc. operates as an online healthcare platform and retail pharmacy company. Its technology-driven platform is cantered on the supply chain of pharmaceutical and healthcare products and healthcare services, encompassing a user’s full life span for all healthcare needs. The firm's retail pharmacy business operates through three models: direct sales, online marketplace and Omni channel initiative. It offers comprehensive online healthcare services, such as online consultation and prescription renewal, chronic disease management, family doctor and consumer healthcare. Its platform allows doctors to practice multisite, acquire and manage targeted patients, conduct healthcare research, exchange academic and clinical knowledge and improve diagnostic and treatment skills. The company was founded on November 30, 2018 and is headquartered in Beijing, China.

Check out other big names from the same industry as 86618.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 86618 is 58.90 CNY — it has decreased by −0.60% in the past 24 hours. Watch JD Health International, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on HKEX exchange JD Health International, Inc. stocks are traded under the ticker 86618.
86618 stock has risen by 2.29% compared to the previous week, the month change is a 26.97% rise, over the last year JD Health International, Inc. has showed a 179.81% increase.
We've gathered analysts' opinions on JD Health International, Inc. future price: according to them, 86618 price has a max estimate of 80.81 CNY and a min estimate of 48.21 CNY. Watch 86618 chart and read a more detailed JD Health International, Inc. stock forecast: see what analysts think of JD Health International, Inc. and suggest that you do with its stocks.
86618 reached its all-time high on Aug 19, 2025 with the price of 63.60 CNY, and its all-time low was 18.30 CNY and was reached on Aug 15, 2024. View more price dynamics on 86618 chart.
See other stocks reaching their highest and lowest prices.
86618 stock is 1.89% volatile and has beta coefficient of 1.27. Track JD Health International, Inc. stock price on the chart and check out the list of the most volatile stocks — is JD Health International, Inc. there?
Today JD Health International, Inc. has the market capitalization of ‪187.08 B‬, it has decreased by −3.21% over the last week.
Yes, you can track JD Health International, Inc. financials in yearly and quarterly reports right on TradingView.
JD Health International, Inc. is going to release the next earnings report on Mar 30, 2026. Keep track of upcoming events with our Earnings Calendar.
86618 earnings for the last half-year are 0.81 CNY per share, whereas the estimation was 0.99 CNY, resulting in a −18.59% surprise. The estimated earnings for the next half-year are 0.60 CNY per share. See more details about JD Health International, Inc. earnings.
JD Health International, Inc. revenue for the last half-year amounts to ‪35.29 B‬ CNY, despite the estimated figure of ‪33.90 B‬ CNY. In the next half-year revenue is expected to reach ‪34.92 B‬ CNY.
86618 net income for the last half-year is ‪2.55 B‬ CNY, while the previous report showed ‪2.17 B‬ CNY of net income which accounts for 17.53% change. Track more JD Health International, Inc. financial stats to get the full picture.
No, 86618 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Sep 4, 2025, the company has ‪3.56 K‬ employees. See our rating of the largest employees — is JD Health International, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. JD Health International, Inc. EBITDA is ‪2.44 B‬ CNY, and current EBITDA margin is 2.37%. See more stats in JD Health International, Inc. financial statements.
Like other stocks, 86618 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade JD Health International, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So JD Health International, Inc. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating JD Health International, Inc. stock shows the buy signal. See more of JD Health International, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.